Clinically Led. Institutionally Ready.

The distributor that connects clinical innovation to institutional adoption.

Surgilinks organizes the clinical, operational, and economic information hospitals need as a product moves from clinical interest toward an informed institutional decision.

Manufacturer Portfolio
Why Promising Products Stall

A product can perform well in the OR.
And still stall in hospital review.

A clinical need can become clear quickly. Institutional adoption rarely does.

Clinical conviction

The value becomes visible in use.

Performance

What happens in the procedure.

Workflow

How use changes the work.

Clinical relevance

Why the difference matters.

The translation gap

Surgilinks was built to connect the two.

Institutional decision

Broader use requires organizational clarity.

Evidence

What supports the conclusion.

Economics & supply

What the institution must sustain.

Implementation

What reliable use requires.

For Hospitals

The process should fit the institution.
Not the other way around.

Surgilinks remains accountable for the work that matters in every pathway: understanding the clinical problem, creating decision clarity, and carrying a sound decision into reliable use.

Clinical understanding
We begin with the problem, not the product pitch. That means understanding the procedure, the current workflow, and the practical consequences before determining what information or support would be useful.
Decision clarity
The hospital defines its process and makes the decision. We help stakeholders identify what matters, develop decision-useful information, and distinguish meaningful evidence from promotional noise.
Operational follow-through
When the decision is to proceed, the work is not finished. We stay accountable for contracting, supply, education, case support, and the practical details required for reliable use.
Questions We Help Surface

Better decisions begin with better questions.

The questions change with the product and the institution. The principle does not: surface what matters early, examine the evidence honestly, and resolve what could prevent reliable use.

01

What problem is the institution actually trying to solve, and where does it create clinical, operational, or financial consequence?

02

What must stakeholders see or understand to judge whether the product represents a meaningful improvement?

03

Which observed effects are repeatable, material, and attributable to the product rather than to the circumstances of a single case?

04

What must be true across workflow, training, supply, contracting, and accountability for the product to work reliably in practice?

Clinical Experience

Clinical experience changes what you know to look for.

Papers and product claims can describe what should happen. Clinical experience helps reveal what actually happens: how teams use a product, where workflow changes, and which details determine whether performance is repeatable.

Because our team has worked alongside surgeons, nurses, and clinical staff, we know how to separate isolated reactions from meaningful patterns. We also know how to identify issues that could prevent reliable use.

Perspective across surgical specialties.

Firsthand exposure across different procedural environments gives our team context for varying workflows, stakeholders, and implementation demands.

EndovascularStructural HeartNeurovascularGeneral SurgeryRoboticsOrthopedicsSpineENTUrologyGynecologyCardiovascularCapital Equipment
Current Portfolio

A focused portfolio of surgical products.

We add products that solve a clear clinical problem, have strong manufacturer support, and fit the way hospitals review, implement, and adopt new technology.

MedicaLock Corporation · Anchor Line

SurgiLock® OR Safety Platform

A single-use platform that helps keep instruments in place and position patients using MedicaLock’s patented ElasTak® technology.

Instrument Platform
Uses ElasTak® adhesive to hold metal and non-metal instruments in place without a magnetic pad.
Positioning Foam
Nonabsorbent foam that grips without tape and is designed to stay in place throughout the procedure.
Available Now
Hjarta Care

XplantR™

A device for removing aortic stent grafts in complex endovascular cases.

  • FDA De Novo authorized
  • Four-SKU explant system
Available Now
Brasseler USA Surgical

Surgical Instrumentation

Surgical instrumentation from an established U.S. manufacturer, supported through Surgilinks for hospital review and sourcing.

  • Broad procedural instrumentation portfolio
  • Clinical review and sourcing support
Available Now
Field Coverage

Senior coverage in active markets.

Our current field team covers the Pacific, Southwest, Mountain West, Ohio Valley, and Southeast. We expand where we have qualified representatives and active hospital opportunities.

Supply Chain Clarity

One contract. Manufacturer-direct fulfillment.

Hospitals contract with Surgilinks. Product is fulfilled through the manufacturer’s inventory and logistics network, preserving supply continuity without an additional local warehousing layer.

Leadership

Leadership with direct clinical and commercial experience.

Brian Thorson
Chairman
  • 38 years in medtech
  • Structural heart and endovascular
  • Commercial strategy
  • Manufacturer partnerships
Drew Thorson
Founder & CEO
  • Clinical commercialization
  • Hospital adoption
  • Value analysis strategy
  • Surgical case support
Mike Schultz
Regional Sales Manager, Southwest
  • 25 years in orthopedics
  • Trauma and reconstruction
  • Biomechanical engineering
  • Southwest market leadership
Regional field leadership

Experienced surgical sales and clinical professionals support account development, clinical engagement, case coverage, and implementation across Surgilinks’ active regions.

For Manufacturers

Focused commercialization for surgical products that need more than coverage.

Surgilinks combines senior field execution, selective portfolio attention, and institutional follow-through so promising products do not disappear after the first strong clinical response.
We work best with manufacturers whose products have strong clinical support and are ready for disciplined market development.
Start a Conversation
01
Senior attention, not portfolio dilution
Experienced leadership stays close to account strategy, field execution, and manufacturer communication.
02
Opportunity development
We originate and advance hospital opportunities rather than waiting for clinical interest to convert itself.
03
Accountability beyond the first case
We remain accountable after the first clinical response. That includes the work required to convert interest into sustained use.
Get In Touch

Start with the problem, not a prescribed process.

Tell us what is happening clinically or operationally, which product is under consideration, and what your organization needs to resolve.

Office
N16 W23233 Stone Ridge Dr, Suite 200
Waukesha, WI 53188